NCT05607147

Brief Summary

10 asymptomatic DHCWs in the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated DHCWs' perceptions of safety and adoption of risk mitigation behavior. Following a baseline survey, finger-prick blood samples were collected twice two weeks apart using an innovative microsampling technique that replaces the need for venipuncture. Samples were processed using an in-house ELISA assay to detect IgM and IgG directed against the Receptor Binding Domain (RBD) of the Spike protein. Weekly Rapid Antigen testing of nasal swab specimens was used to document Antigen negativity during the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 31, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 7, 2022

Completed
4 months until next milestone

Results Posted

Study results publicly available

March 20, 2023

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

16 days

First QC Date

October 31, 2022

Results QC Date

December 12, 2022

Last Update Submit

August 10, 2023

Conditions

Keywords

Dental Healthcare WorkerTestingSeroprevalencePerception of SafetyAdoption of risk mitigation practice

Outcome Measures

Primary Outcomes (5)

  • Dental Health Care Worker (DHCW) Willingness to Participate in the Study

    Number of Dental Health Care Workers (DHCWs) approached to enroll 10 consenting subjects to participate in the study

    Day 1

  • DHCW Willingness/Ability to Follow Through With the Study Surveys, Triage and Testing

    Percentage of Dental Healthcare workers (DHCW)s who complete the study steps of surveys, triage and testing

    Day 28

  • DHCW Test Completion

    Percentage of DHCWs with completed SARS-CoV-2 test completed

    Day 28

  • DHCW Ease of Complying With Protocol

    Number of DHCWs who reported ease of complying with protocol as their choices on questions on the survey enquiring ease at start-of-study, end-of-study

    Day 28

  • Number of DHCW With Complete Surveys

    Number of participants with complete Start-of-study, Triage and End-of-Study surveys

    Through study completion (3 months)

Secondary Outcomes (3)

  • SARS CoV2 Rapid Antigen Testing (Point-of-care)- Number of Participants Who Tested Positive

    28 days

  • Positive Antibody Testing

    28 days

  • Number of DCHWs Who Reported Feeling Safe and Comfortable Reporting to Work

    28 days

Study Arms (1)

SARS-CoV-2 testing

OTHER

There is only one arm in this study- the study is a non-randomized pilot. All the subjects will be tested for SARS CoV 2 viral Antigen and antibody to the virus as described.

Device: Testing for SARS CoV2 Antigen and Antibody

Interventions

Antigen testing: Rapid Antigen testing (Point-of-care) Antibody testing: ELISA testing of microsampling 'finger-prick' specimen DHCW Survey for adoption of risk mitigation practices and for perceptions of safety

SARS-CoV-2 testing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dental healthcare workers (DHCW)s employed at Rutgers School of Dental Medicine

You may not qualify if:

  • Previous participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers School of Dental Medicine

Newark, New Jersey, 07103, United States

Location

Related Publications (3)

  • 1. American Dental Association COVID-19 Toolkit - Update to Office Procedures During COVID-19. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/coronavirus/update_to_office_procedures_during_covid19.pdf accessed on November 11, 2021.

    BACKGROUND
  • Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020 Nov;151(11):815-824. doi: 10.1016/j.adaj.2020.09.005.

    PMID: 33071007BACKGROUND
  • Shirazi S, Stanford CM, Cooper LF. Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests. J Am Dent Assoc. 2021 Jul;152(7):514-525.e8. doi: 10.1016/j.adaj.2021.04.019. Epub 2021 May 4.

    PMID: 34176567BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Gayathri Subramanian, PhD, DMD
Organization
Rutgers School of Dental Medicine, Newark, New Jersey, United States

Study Officials

  • Cecile A Feldman, DMD, MBA

    Rutgers School of Dental Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Pilot study to assess feasibility of testing dental healthcare workers for seropositivity and antigen positivity for SARS-CoV-2 (Rapid Antigen point-of-care testing).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 31, 2022

First Posted

November 7, 2022

Study Start

January 26, 2021

Primary Completion

February 11, 2021

Study Completion

February 11, 2021

Last Updated

August 24, 2023

Results First Posted

March 20, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

If the COVID test results show that a participant is positive for COVID-19, the study staff will tell the participant the results. The study staff will be required to give the participant's name to the state's Department of Public Health if the participant tests positive because this is the law. At the end of the study, de-identified data will be provided to the National Coordinating Center.

Locations